Martin P, Bartlett NL, Blum KA, et al. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204.

In the conflict-of-interest disclosure paragraph on page 1203, the sentence “S.C.-K. served as a consultant for Vigilant.” is incorrect. Author Selina Chen-Kiang had no competing financial interests to declare. The error has been corrected in the online version of the article.